Message from IGCA & CGCA: What we have learnt and what we need to improve

Jiafu Ji
2016-01-01
Abstract:CGCA has been the main protagonist in launching collaborative research projects and effecting standardized surgical and multimodal treatment for gastric cancer in China. The number of pivotal clinical trials has soared dramatically over the two decades. Some trials such as CLASS-01 study and RESLVE study showcase the potential of solving important clinical questions. We have trained thousands of surgeons in China in the forms of gastric surgery demos and itinerant lectures. Many institutions in China now possess mature and highly evolved standardized practice and research platform for gastric cancer.We initiated unique centralized cancer bio-bank and Gastrointestinal Cancer League, each having accumulated over thirty thousand gastric cancer cases, to promote collaboration and foster innovation in research. We have conducted epidemiological and intervention studies in high incidence area of gastric …
What problem does this paper attempt to address?